Table 3.
Operative and 90-day outcomes for RASP and OSP cohorts
| Outcome | RASP N (%) or Mean ± SD | OSP N (%) or Mean ± SD | p value |
|---|---|---|---|
| Prostate volume on pathology (mL) | 123.6 ± 40.8 | 122.9 ± 53.6 | 0.98 |
| Operation duration (min) | 161.3 ± 30.1 | 79 ± 27.4 | 0.008* |
| Intraoperative blood loss (mL) | 218.8 ± 181.9 | 835.7 ± 301.2 | 0.0001* |
| Length of hospital stay (days) | 2.25 ± 0.5 | 5.5 ± 1.7 | 0.0001* |
| 90-day transfusion rate | 0/4 (0%) | 13/28 (46.4%) | 0.13 |
| No. units of packed red blood cells transfused | 0 | 1.5 ± 2.3 | 0.17 |
| 90-day complication rate | 0/4 (0%) | 16/28 (57.1%) | 0.10 |
| Clavien I1 | 0/4 (0%) | 2/28 (7.1%) | 1.00 |
| Clavien II | 0/4 (0%) | 11/28(39.3%) | 0.27 |
| Clavien III | 0/4 (0%) | 4/28 (14.3%) | 1.00 |
| Clavien IV | 0/4 (0%) | 1/28 (3.6%) | 1.00 |
RASP: robotic-assisted simple prostatectomy; SD: standard deviation; OSP: open simple prostatectomy; CCI: Charlson Comorbidity Index; TRUS: transrectal ultrasonography; ASA: American Society of Anesthesiologists.
1
Note: Some patients had multiple complications resulting in multiple Clavien grades assigned.
*
p < 0.05 considered statistically significant.